Stock listing

LSE:ONT Oxford Nanopore Technologies PLC Share Price

Home listing (LSE) of Oxford Nanopore Technologies PLC

Follow Oxford Nanopore Technologies PLC into a list and get an email when it puts out news.

Share price · LSE:ONT

188.70p GBX (pence) -7.90 (-4.0%)

Close on Nov 20, 2026

Past year +52.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
186.90p – 198.00p GBX (pence)Nov 20, 2026
Volume
950,534 sharesNov 20, 2026
Market cap
£1.85B GBPAt the close on Nov 20, 2026 · price × 980.9M shares outstanding
52-week range
95.61p – 239.40p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£5.61M GBPMedian day 1.80M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Oxford Nanopore Technologies PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:ONT · Home188.70p GBX (pence)-7.90 (-4.0%)950,534198.00p198.00p186.90p196.60pClose on Nov 20, 2026
OTC:ONTTF$2.50 USD-0.20 (-7.4%)500$2.50$2.50$2.50$2.70Close on Nov 20, 2026
OTC:OXFYY$10.84 USD-0.595 (-5.2%)1,000$10.84$10.84$10.84$11.43Close on Nov 18, 2026
Frankfurt:4R0€2.364 EUR-0.008 (-0.3%)—€2.266€2.364€2.266€2.372Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:ONT · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
188.70p-7.90-4.0%198.00p198.00p186.90p950,534
196.60p-0.70-0.4%197.70p204.40p195.90p552,943
197.30p-6.90-3.4%201.00p203.56p195.70p1,483,997
204.20p+5.20+2.6%199.00p205.20p197.50p1,042,952
199.00p-2.40-1.2%199.00p202.80p196.80p1,103,552
201.40p-3.80-1.9%203.80p206.18p194.78p1,250,419
205.20p+4.20+2.1%203.60p206.82p202.54p714,830
201.00p-9.40-4.5%213.00p213.00p201.00p1,756,986
210.40p+4.60+2.2%207.80p213.20p205.80p1,683,223
205.80p+1.00+0.5%202.00p206.80p198.64p965,632
204.80p-5.60-2.7%210.40p213.80p199.90p1,820,314
210.40p-5.40-2.5%217.80p220.00p209.60p1,853,810
215.80p+2.80+1.3%210.00p218.80p205.20p1,220,795
213.00p-9.60-4.3%227.80p227.80p211.20p1,201,805
222.60p-10.80-4.6%230.00p232.67p222.40p1,661,458
233.40p-1.60-0.7%233.20p237.00p230.00p876,778
235.00p+9.40+4.2%225.80p239.40p222.69p2,874,360
225.60p+10.60+4.9%214.20p225.60p210.60p1,335,239
215.00p+4.60+2.2%209.80p215.00p207.60p1,050,544
210.40p-1.00-0.5%210.20p213.20p205.40p869,396
211.40p-4.80-2.2%214.40p220.00p211.00p1,178,092
216.20p+7.40+3.5%208.60p216.20p204.00p4,650,405
208.80p-0.40-0.2%210.00p213.00p201.00p1,808,136
209.20p+9.20+4.6%200.40p210.20p200.20p1,790,959
200.00p-9.60-4.6%208.40p215.60p196.60p3,219,887
209.60p+1.00+0.5%206.60p212.00p204.20p1,073,336
208.60p-2.40-1.1%212.00p212.80p203.60p1,675,885
211.00p-6.00-2.8%218.80p219.80p211.00p2,840,056
217.00p+3.60+1.7%216.40p218.80p212.20p1,442,846
213.40p+12.60+6.3%203.60p213.60p199.80p4,107,852
200.80p-19.80-9.0%217.00p219.00p198.40p3,451,283
220.60p-10.20-4.4%227.20p227.40p212.20p6,585,249
230.80p+10.80+4.9%220.00p238.80p219.60p5,725,027
220.00p-3.20-1.4%221.00p227.00p212.20p2,819,793
223.20p+9.20+4.3%211.00p237.00p207.80p7,474,316
214.00p-3.60-1.7%218.80p220.80p206.50p14,809,223
217.60p+18.20+9.1%201.80p218.60p187.35p5,281,206
199.40p+16.90+9.3%182.70p201.60p178.79p4,928,150
182.50p+0.90+0.5%182.00p187.40p179.10p2,381,529
181.60p+8.10+4.7%175.00p182.20p173.80p2,057,090
173.50p-2.00-1.1%175.00p178.65p172.30p1,486,640
175.50p-2.50-1.4%175.00p180.34p175.00p5,485,120
178.00p+5.80+3.4%173.90p180.00p173.60p1,800,697
172.20p-2.20-1.3%174.50p177.30p172.20p3,540,149
174.40p+3.60+2.1%167.80p179.00p167.80p3,615,869
170.80p+9.50+5.9%162.20p171.30p161.40p1,876,808
161.30p+3.00+1.9%159.80p163.40p157.10p1,349,539
158.30p+4.30+2.8%152.90p158.60p152.90p1,797,254
154.00p-2.90-1.8%156.10p157.80p152.10p1,076,812
156.90p+4.20+2.8%154.00p158.60p151.20p1,044,315
152.70p-5.50-3.5%156.90p161.10p148.00p3,267,741
158.20p-0.60-0.4%157.20p160.10p155.40p1,693,633
158.80p+1.30+0.8%160.00p161.30p155.10p1,111,150
157.50p-3.90-2.4%160.20p163.00p155.20p1,441,965
161.40p-11.90-6.9%153.00p166.80p152.70p8,433,103
173.30p+3.30+1.9%172.00p180.30p169.40p1,759,649
170.00p+10.00+6.3%160.00p173.00p157.70p1,666,855
160.00p-16.10-9.1%172.60p175.30p158.50p2,593,195
176.10p-5.10-2.8%180.00p183.80p175.80p4,476,288
181.20p-0.60-0.3%184.10p191.40p181.20p3,093,883
181.80p-1.20-0.7%182.80p184.40p176.10p3,331,648
183.00p+16.30+9.8%166.20p183.00p163.90p3,852,920
166.70p-3.30-1.9%173.20p179.20p164.80p4,811,008
170.00p+5.50+3.3%164.50p170.00p157.10p7,900,456
164.50p+24.80+17.8%141.90p164.50p140.95p10,579,945
Ticker
LSE:ONT
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LSE
Currency
GBX

What changed lately

Latest news

Issue of Equity and Total Voting Rights

Nov 2, 2026

Closed 215.80p (+1.3%) on Nov 3, 2026

Director/PDMR Shareholding

Oct 12, 2026

Closed 211.00p (-2.8%) on Oct 13, 2026

Holding(s) in Company

Oct 2, 2026

Closed 223.20p (+4.3%) on Oct 2, 2026

Preliminary injunction against MGI Tech GmbH

Sep 16, 2026

Closed 161.30p (+1.9%) on Sep 16, 2026

Appointment of CDPO

Aug 25, 2026

Closed 183.00p (+9.8%) on Aug 25, 2026

All Oxford Nanopore Technologies PLC news

Oxford Nanopore Technologies PLC on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
33 in the last 12 months · 193 in all · newest Nov 18, 2026 · oldest 2000
Decks
15 decks · latest Aug 19, 2026

Where Oxford Nanopore Technologies PLC is listed

ListingExchangeCountryCurrency
LSE:ONT · Home listing · This pageLSEUnited KingdomGBX
gettex:4R0gettexGermanyEUR
OTC:ONTTFOTCUnited StatesUSD
LS Exchange:A3C307LS ExchangeGermanyEUR
OTC:OXFYYOTCUnited StatesUSD
Tradegate:4R0TradegateGermanyEUR
Lang & Schwarz:A3C307Lang & SchwarzGermanyEUR
Aquis:ONTLAquisUnited KingdomGBX
Turquoise:ONTLTurquoiseUnited KingdomGBX
Frankfurt:4R0FrankfurtGermanyEUR
Stuttgart:4R0StuttgartGermanyEUR
Dusseldorf:4R0DusseldorfGermanyEUR
Hamburg:4R0HamburgGermanyEUR
Munich:4R0MunichGermanyEUR
Hanover:4R0HanoverGermanyEUR
Xetra:4R0XetraGermanyEUR

Valuation

EV/sales 7.6× against a median of 5.3×: 7th lowest of 11 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
£1.71B GBP
P/E
Loss
EV/sales
7.6×
EV/EBITDA
Negative EBITDA
Price/book
4.4×
Gross margin
58.6%
Operating margin
−69.4%
Net margin
−64.8%
Debt to equity
0.1×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Oxford Nanopore Technologies PLC · LSE:ONTUS$2.42BUS$2.23Bn/a7.6×n/a4.4×−64.8%0.1×n/a
Joinn Laboratories (China) Co., Ltd. Class A · SSE:603127US$3.04BUS$2.66B17.7×9.6×n/a2.2×61.6%0.0×n/a
MGI Tech Co., Ltd. Class A · SSE:688114US$2.92BUS$2.53Bn/a5.5×n/a2.8×−9.5%0.2×n/a
Neuland Laboratories Ltd. · NSE:NEULANDLABUS$2.86BUS$2.80B58.5×11.3×36.8×13.1×19.6%0.2×n/a
Shanghai Haoyuan Chemexpress Co. Ltd. Class A · SSE:688131US$2.72BUS$2.61B56.7×5.0×n/a5.3×9.3%0.3×n/a
Veracyte, Inc. · NASDAQ:VCYTUS$2.03BUS$1.70B16.0×2.9×14.0×1.4×21.8%0.0×1.34
OneSource Specialty Pharma Limited · NSE:ONESOURCEUS$1.99BUS$2.18Bn/a12.0×50.9×3.1×−0.1%0.3×n/a
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A · SSE:603456US$1.97BUS$1.77B22.0×2.2×n/a1.5×11.3%0.0×n/a
Azenta, Inc. · NASDAQ:AZTAUS$1.96BUS$1.63Bn/a2.6×n/a1.4×−26.9%0.0×1.59
Syngene International Ltd. · NSE:SYNGENEUS$1.96BUS$1.96B97.5×5.2×20.0×3.7×5.3%0.1×n/a
Cohance Lifesciences Ltd · NSE:COHANCEUS$1.91BUS$1.88B167×8.1×55.1×4.5×5.0%0.1×n/a
Median of the othersUS$2.01BUS$2.07B56.7×5.3×36.8×3.0×7.3%0.1×1.47

Forecasts

Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
223.25 GBX · Analysts' mean
EPS, year to Dec 2026
-0.10 · 9 analysts
Revenue, year to Dec 2026
269.6M · 10 analysts

Team and board

Officers

OfficerRole
Francis Van ParysChief Executive Officer
Nick KeherChief Financial Officer
Hannah CooteVice President, Associate General Counsel
Jordan HermanSVP, General Counsel
Alvaro CorreiaVP, Global Supply Chain
Ant JonesVP, Engineering
Chris HannanVP, Quality Assurance and Regulatory Affairs
David StoddartVP, Sample Technology
Gretchen WeightmanVP & GM, APAC
Jayne WallaceVP, Nanopore Research and Protein Sequencing
Jeremy BryarVP, Manufacturing
Kristen StoopsVP, Strategic Marketing and Business Development
Martyn AndrewsVP, Intellectual Property
Nirmala SantiapillaiVP, Commercial Operations
Oliver HartwellVP, Strategic Planning
Phil WatkinsVP, Finance
Rhodri DaviesVP, Operations
Sarah WoodsVP, Global IT
Sissel JuulVP, Applications
Stephanie AbernathyVP, Commercial
Thomas BrayVP, Business Development
Tonya McSherryVP Commercial, EMEAI
Andrew WatsonChief Information Officer
Conor McKechnieChief Marketing and Communications Officer
David MillerChief Development and Product Officer
Davide ManisseroChief Medical Officer
Lakmal JayasingheChief Scientific Officer
Sebastian KronmuellerChief Business Development Officer
Tina St. LegerChief People Officer

Board

DirectorRole
Duncan Tatton-BrownChairman of the Board
Adrian HennahNon-executive Director
Daniel MahonyNon Executive Director
Francis Van ParysChief Executive Officer
Heather PrestonNon Executive Director
John O'HigginsNon-executive Director
Kate PriestmanNon Executive Director
Nick KeherChief Financial Officer
Sarah FortuneNon Executive Director

Events

Next results
Mar 3, 2027 (expected)
QuarterResultsShare move
Q2 2025Sep 2, 2025 · After close+1.2%
Quarter to Mar 31, 2025Jun 10, 2025 · After close+0.8%
Q4 2022Mar 21, 2023+12.0%
Q2 2022Sep 13, 2022+8.3%
Q4 2021Mar 22, 2022−5.9%
Q2 2021Sep 30, 2021

Open Events

Decks

DeckKindSlidesDate
H1 2026 Earnings PresentationEarnings46 slidesAug 19, 2026
J.P. Morgan Healthcare Conference 2026Conference18 slidesJan 12, 2026
H1 2025 Earnings PresentationEarnings30 slidesSep 2, 2025
FY2024 Earnings PresentationEarnings41 slidesMar 4, 2025
J.P. Morgan Healthcare Conference 2025Conference27 slidesJan 13, 2025
H1 2024 Earnings PresentationEarnings32 slidesSep 3, 2024
FY2023 Earnings PresentationEarnings42 slidesMar 6, 2024
JPM 2024Conference30 slidesJan 9, 2024
Investor Day (October 2023)Investor day171 slidesOct 19, 2023
H1 2023 Earnings PresentationEarnings36 slidesSep 6, 2023
All 15 decks
DeckKindSlidesDate
FY2022 Earnings PresentationEarnings38 slidesMar 21, 2023
H1 2022 Earnings PresentationEarnings33 slidesSep 13, 2022
FY2021 Earnings PresentationEarnings36 slidesMar 22, 2022
JP Morgan Healthcare Conference January 2022Conference27 slidesJanuary 2022
ESG Presentation (September 2021)Sustainability8 slidesSeptember 2021

Open Decks

Financials

Annual, in GBP

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue223.9M183.2M169.7M198.6M133.7M113.9M52.1M32.5M13.8M4.53M
Cost of revenue92.6M77.8M79.2M74.8M60.5M67.0M26.4M16.5M7.06M3.88M
Gross profit131.3M105.4M90.5M123.8M73.2M46.9M25.6M16.0M6.73M645.0K
Research and development97.7M98.9M103.8M69.2M76.0M48.6M40.5M37.1M35.0M38.1M
Selling, general and administrative188.9M158.8M155.2M157.4M161.8M71.4M66.1M41.1M23.6M
Operating income-155.3M-152.3M-168.6M-98.5M-164.5M-73.1M-80.9M-62.2M-65.9M-65.0M
Depreciation and amortization49.8M43.3M41.6M31.9M24.7M17.3M14.8M6.36M1.79M1.34M
EBITDA-105.5M-109.0M-127.0M-66.6M-139.8M-55.7M-66.0M-55.8M-64.1M-63.6M
Interest expense2.80M3.60M2.21M1.63M908.0K747.0K614.0K423.0K0
Income before tax-139.9M-140.0M-149.8M-83.4M-166.0M-73.2M-80.5M-62.0M-65.9M-64.7M
Income tax5.30M6.20M4.74M7.61M1.61M-11.9M-8.27M-8.91M-9.33M-5.58M
Net income-145.2M-146.2M-154.5M-91.0M-167.6M-61.2M-72.2M-53.1M-56.5M-59.1M
Earnings per share, basic-0.15-0.16-0.190.110.23-0.08-0.09-0.07-0.10-0.11

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents181.1M199.5M220.5M356.8M487.8M80.9M13.1M35.3M57.8M64.1M
Short-term investments74.2M138.9M49.5M119.4M130.6M58.0M10.0M60.0M
Receivables72.4M62.7M61.5M62.9M54.8M52.2M66.0M12.7M4.50M1.39M
Inventory81.5M99.5M101.5M87.7M63.1M35.6M20.0M18.6M6.45M340.0K
Current assets420.0M520.1M447.2M638.0M750.6M203.2M104.5M142.3M97.9M155.5M
Property, plant and equipment61.9M66.3M49.9M37.3M47.2M53.2M43.4M26.5M21.4M
Total assets622.5M742.0M777.1M823.9M841.9M281.2M164.7M175.2M119.3M158.9M
Accounts payable108.9M102.3M78.4M80.2M72.9M31.0M12.0M10.5M3.64M3.73M
Current liabilities118.0M111.5M89.2M91.5M105.0M72.2M36.7M21.8M15.2M13.7M
Long-term debt09.50M9.50M9.50M9.50M
Total debt41.5M46.0M41.7M09.50M23.6M19.1M9.50M9.50M
Total liabilities159.2M155.7M133.2M130.3M137.9M95.3M55.2M32.3M25.7M13.7M
Shareholders' equity463.3M586.3M643.9M693.6M704.0M185.9M109.5M142.9M93.6M144.2M
Shares outstanding961.0M897.8M834.0M823.7M821.6M794.7M794.7M794.7M541.1M539.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-70.6M-109.9M-137.3M-63.8M-53.2M-63.8M-48.7M-55.5M-66.3M-51.2M
Capital spending-3.50M-13.9M-5.91M-8.63M-21.5M-26.5M-30.3M-17.8M-19.7M-3.03M
Free cash flow-74.1M-123.8M-143.2M-72.5M-74.7M-90.3M-79.0M-73.3M-86.1M-54.2M
Cash from investing56.3M15.0M-61.8M-51.4M-162.0M-26.9M28.5M-65.4M-19.6M-2.50M
Cash from financing-2.10M73.6M64.7M-13.7M622.9M158.6M-1.99M98.4M79.7M65.1M
Share buybacks164.0M276.0K100.3M
Change in cash-16.4M-21.3M-134.4M-128.9M407.7M67.8M-22.2M-22.5M-6.28M11.5M

Open Financials

Cap table

Built by 6ix from Oxford Nanopore Technologies PLC’s releases

Common shares
980,902,212
Fully diluted
980,902,212

Fully diluted

LineShares
Common shares980,902,212

Share count over time

CountShares
Nov 22, 2026980,902,212

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
T. Rowe Price International Discovery Fund7.44MUS$11.4MJul 31, 2026
Vanguard Total International Stock Index Fund6.35MUS$9.75MJul 31, 2026
Vanguard Developed Markets Index Fund4.27MUS$7.02MJun 30, 2026
iShares Core MSCI EAFE ETF3.88MUS$5.96MJul 31, 2026
Inception Portfolio2.33MUS$3.84MJun 30, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund1.81MUS$2.79MJul 31, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio1.81MUS$2.99MJun 30, 2026
iShares MSCI EAFE Small-Cap ETF1.6MUS$2.46MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF1.28MUS$2.11MJun 30, 2026
Vanguard European Stock Index Fund1.02MUS$1.56MJul 31, 2026
All 37 holders
HolderSharesValueAs of
Schwab International Small-Cap Equity ETF890KUS$1.72MMay 31, 2026
iShares Core MSCI Total International Stock ETF732KUS$1.12MJul 31, 2026
iShares Core MSCI International Developed Markets ETF713KUS$1.09MJul 31, 2026
Dimensional International Small Cap ETF325KUS$496KJul 31, 2026
The United Kingdom Small Company Series306KUS$470KJul 31, 2026
Vanguard Total World Stock Index Fund296KUS$454KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account284KUS$467KJun 30, 2026
Fidelity Total International Index Fund252KUS$385KJul 31, 2026
International Core Equity 2 Portfolio251KUS$385KJul 31, 2026
Fidelity SAI International Small Cap Index Fund127KUS$195KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio125KUS$206KJun 30, 2026
Vanguard ESG International Stock ETF78,344US$151KMay 31, 2026
Dimensional VA International Small Portfolio55,177US$84,689Jul 31, 2026
World ex U.S. Core Equity Portfolio50,039US$76,803Jul 31, 2026
iShares MSCI Europe Small-Cap ETF49,516US$76,001Jul 31, 2026
iShares MSCI United Kingdom Small-Cap ETF41,916US$80,767May 31, 2026
iShares MSCI World Small-Cap ETF38,726US$74,620May 31, 2026
T. Rowe Price Global Allocation Fund30,136US$46,255Jul 31, 2026
International Social Core Equity Portfolio28,273US$43,395Jul 31, 2026
State Street(R) SPDR(R) Portfolio Europe ETF28,178US$46,412Jun 30, 2026
International Sustainability Core 1 Portfolio19,057US$29,250Jul 31, 2026
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund15,624US$23,843Jul 31, 2026
Avantis International Small Cap Equity ETF9,656US$18,606May 31, 2026
Brighthouse/Dimensional International Small Company Portfolio7,162US$11,794Jun 30, 2026
WisdomTree BioRevolution Fund6,496US$10,700Jun 30, 2026
Avantis Responsible International Equity ETF1,997US$3,848May 31, 2026
Goldman Sachs MSCI World Private Equity Return Tracker ETF1,466US$2,830May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Francis Van Parys
Chief Executive Officer
Sale967GBP 2.02GBP 1,949Nov 18, 2026
Adrian Hennah
Non-Executive Director
Buy24,000GBP 2.16GBP 51,936Oct 12, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Heather Preston
Other companies: Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past)
Non Executive Director · Since at least May 1, 2026
Adrian Hennah
Other companies: Unilever PLC (Non-Executive Director · Since at least May 13, 2026)
Non-executive Director · Since at least Oct 12, 2026
Francis Van Parys
Other companies: Danaher Corporation (Chief Executive Officer · Dec 8, 2025 – Nov 5, 2026 · Past)
Chief Executive Officer · Since at least Oct 20, 2026
John O'Higgins
Other companies: Technip Energies NV (Independent Director, Chair of the Board and Chair of the Nomination and Governance Committee · Since at least Apr 30, 2026)
Non-executive Director · Since at least May 1, 2026
Alvaro CorreiaVP, Global Supply Chain · Since at least Nov 4, 2026
Andrew WatsonChief Information Officer · Since at least Aug 19, 2026
Ant JonesVP, Engineering · Since at least Nov 4, 2026
Chris HannanVP, Quality Assurance and Regulatory Affairs · Since at least Nov 4, 2026
Conor McKechnieChief Marketing and Communications Officer · Since at least Aug 25, 2026
Daniel MahonyNon Executive Director · Since at least May 1, 2026
All 36 people
PersonSeat
Davide ManisseroChief Medical Officer · Since at least Aug 19, 2026
David MillerChief Development and Product Officer · Since at least Aug 25, 2026
David StoddartVP, Sample Technology · Since at least Nov 4, 2026
Duncan Tatton-BrownChairman of the Board · Since at least May 1, 2026
Gretchen WeightmanVP & GM, APAC · Since at least Mar 17, 2026
Hannah CooteVice President, Associate General Counsel · Since at least Aug 19, 2026
Jayne WallaceVP, Nanopore Research and Protein Sequencing · Since at least Nov 4, 2026
Jeremy BryarVP, Manufacturing · Since at least Nov 4, 2026
Jordan HermanSVP, General Counsel · Since at least Nov 5, 2026
Kate PriestmanNon Executive Director · Since at least May 1, 2026
Kristen StoopsVP, Strategic Marketing and Business Development · Since at least Nov 4, 2026
Lakmal JayasingheChief Scientific Officer · Since at least Mar 4, 2025
Martyn AndrewsVP, Intellectual Property · Since at least Nov 4, 2026
Nick KeherChief Financial Officer · Since at least Oct 14, 2026
Nirmala SantiapillaiVP, Commercial Operations · Since at least Nov 4, 2026
Oliver HartwellVP, Strategic Planning · Since at least Nov 4, 2026
Phil WatkinsVP, Finance · Since at least Nov 4, 2026
Rhodri DaviesVP, Operations · Since at least Nov 4, 2026
Sarah FortuneNon Executive Director · Since at least May 1, 2026
Sarah WoodsVP, Global IT · Since at least Nov 4, 2026
Sebastian KronmuellerChief Business Development Officer · Since at least Oct 20, 2026
Sissel JuulVP, Applications · Since at least Nov 4, 2026
Stephanie AbernathyVP, Commercial · Since at least Nov 4, 2026
Thomas BrayVP, Business Development · Since at least Nov 4, 2026
Tina St. LegerChief People Officer · Since at least Aug 19, 2026
Tonya McSherryVP Commercial, EMEAI · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Oxford Nanopore Technologies PLC.